Table 1 Clinical characteristics of study population at the age of 50 years
From: Contribution of SLC7A1 genetic variant to hypertension, the TAMRISK study
Cases (n = 412) | Controls (n = 771) | P | |
|---|---|---|---|
Age (years) | 50 ± 0 | 50 ± 0 | |
BMI (kg/m2) | 28.6 ± 5.1 | 25.4 ± 3.6 | <0.001 |
Haemoglobin (g/l) | 147.2 ± 13.2 | 143.90 ± 13.6 | <0.001 |
Cholesterol (mmol/l) | 5.40 ± 0.97 | 5.40 ± 0.92 | 0.965 |
HDL cholesterol (mmol/l) | 1.56 ± 0.45 | 1.67 ± 0.44 | <0.001 |
LDL cholesterol (mmol/l) | 3.17 ± 0.87 | 3.21 ± 0.84 | 0.512 |
Triglycerides (mmol/l) | 1.55 ± 1.20 | 1.17 ± 0.68 | <0.001 |
Glucose (mmol/l) | 5.14 ± 1.20 | 4.84 ± 0.55 | <0.000 |
Systolic blood pressure (mm Hg) | 142.93 ± 16.17 | 129.75 ± 14.66 | <0.000 |
Diastolic blood pressure (mm Hg) | 92.92 ± 8.95 | 84.44 ± 9.40 | <0.000 |
Exercise (at least twice a week) % | 33.8 | 28.0 | 0.048 |
Diabetes % | 11.8 | 0 | <0.000 |
Myocardial infarction % | 2.5 | 0 | <0.000 |
Family history of hypertension % | 71.3 | 42.2 | <0.000 |
Current smoking % | 19 | 19 | |
Gender (male) % | 58.4 | 56.8 | 0.319 |